New Whitepaper: Molecular Detectives Lead to Personalized Medicine

The nostalgic feeling associated with doctors’ house calls reflects a classic one-to-one experience. However, today’s medical technology may have one-upped this approach through the emergence of “personalized medicine.” This new methodology relies on biomarkers to diagnose and establish treatment protocols based on each person’s unique characteristics. Furthermore, personalized medicine may transform the overall medical industry by enabling health-care providers to shift their emphasis from response to prevention.

Understanding the science behind personalized medicine is the subject of our most recent whitepaper titled “Biomarker. Molecular Detective: Personalized Medicine; the Next Generation of Diagnosis and Treatment” authored by OneBeacon Technology Risk Control Manager Mike Campbell. In this whitepaper, we explain biomarkers and how they can be used for detection and customized treatment, the FDA view, and the associated risks. You can also learn about our life sciences risk management capabilities on our website.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s